It’s commonly known as the cat parasite and has found itself in the headlines after medication prices recently skyrocketed in America. Now researchers at the University of Glasgow have found a potential new weakness in the toxoplasmosis-causing parasite, potentially paving the way for new drug development for the disease.
In new a study, published in PLOS Pathogens, scientists at the University of Glasgow’s Wellcome Centre for Molecular Parasitology have identified a key enzyme in the Toxoplasma parasite that is crucial for its survival, and may also be a potential new drug target
FoodWorld 